Literature DB >> 29649619

Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.

Keith M Sullivan1, Mitchell Horwitz2, Ifeyinwa Osunkwo3, Nirmish Shah4, John J Strouse5.   

Abstract

Mesh：

Year:  2018        PMID： 29649619     DOI： 10.1016/j.bbmt.2018.04.001

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  5 in total

Review 1.  How I treat refractory chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Adela R Cardones; Keith M Sullivan
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

2.  Gene therapy for sickle cell disease: where we are now?

Authors:  Julie Kanter; Corey Falcon
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Remission is not maintained over 2 years with hematopoietic stem cell transplantation for rheumatoid arthritis: A systematic review with meta-analysis.

Authors:  Sathish Muthu; Madhan Jeyaraman; Rajni Ranjan; Saurabh Kumar Jha
Journal:  World J Biol Chem       Date:  2021-11-27

Review 4.  Let's Get Back to Normal? COVID-19 and the Logic of Cure.

Authors:  Maria Berghs
Journal:  Front Sociol       Date:  2022-04-12

5.  Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research.

Authors:  Hae Lin Cho; Scott Y H Kim; Courtney Fitzhugh; Matthew Hsieh; John Tisdale; Christine Grady
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-19       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.